The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

In this prospective observational study, immune protection against H5N1 and H7N9 avian influenza virus (AIV) was almost absent prior to vaccination. However, seasonal influenza vaccines induced a ...

An infectious disease expert says the relatively mild cases of avian influenza detected so far among dairy workers don’t warrant making a vaccine available to them, even as they work to contain ...

To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu vaccine development. The vaccine aims to combat current bird flu strains in ...

Influenza A(H5N1) predominately affects wild birds and poultry. Credit: Pordee_Aomboon via Shutterstock. With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...